Novel Corona virus (COVID-19)

Corona contagions are positive sense single stranded RNA contagions that beget infection in nose, sinuses, or upper throat. It belongs to family of SARS and MERS. COVID-19 is the illness caused by SARS-COV-2, first outbreak does Wuhan megacity in China.

The pathogenesis of COVID-19 isn't defined but reports from numerous countries indicate that the contagion has the same medium by which it enters or invades host cells as SARS-COV. The origin of SARS-CoV-2 isn't well- established, still, it's established that batons are the fountainhead of affiliated contagions and that mortal to mortal transmission plays a critical part in its pathogenesis After entering into target cells following Shaft protein association with its receptor, viral RNA is reprised and polyadenylated, and encodes colorful structural andnon-structural polypeptide genes. 

These polyproteins are adhered by proteases that parade chymotrypsin-suchlike exertion. Although transmembrane serine protease 2 (TMPRSS2) is the major protease associated with CoV activation and has been linked to SARS-CoV-2 activation, recent substantiation from single cell RNA-sequencing (scRNA-seq) analysis shows that ACE2 and TMPRSS2 aren't expressed in the same cell suggesting the involvement of other proteases similar as cathepsin B and L in this process.

In general, pattern recognition receptors (PRRs) fete overrunning pathogens including contagion’s. Contagions evoke several crucial host vulnerable responses similar as adding the release of seditious factors, induction and development of dendritic cells (DCs) and adding the conflation of type I interferons (IFNs), which are important in limiting viral spread. Both the ingrain and acquired vulnerable response is actuated by SARS-CoV-2. CD4 T cells stimulate B cells to produce contagion-specific antibodies including immunoglobulin (Ig) G and IgM and CD8 T cells directly kill contagion-infected cells. T coadjutor cells producer-inflammatory cytokines and intercessors to help the other vulnerable cells. SARS-CoV-2 can block the host vulnerable defense by suppressing T cell functions by converting their programmed cell deathe.g., by apoptosis. Likewise, the host product of complement factors similar as C3a and C5a and antibodies are critical in combating the viral infection

    Related Conference of Novel Corona virus (COVID-19)

    October 24-25, 2024

    5th International Conference on Immunology And Immunotherapy

    Zurich, Switzerland
    November 26-27, 2024

    38th International Conference on Immunology

    Madrid, Spain
    June 16-17, 2025

    19th International Conference on European Immunology

    Frankfurt, Germany

    Novel Corona virus (COVID-19) Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in